Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
clinical trials
fda
3
×
life sciences
3
×
national blog main
boston
abbvie
access biotechnology
access industries
alexion pharmaceuticals
amyotrophic lateral sclerosis (als)
anemia
atlas ventures
autoimmune disorders
black diamond therapeutics
bladder cancer
blood diseases
blood disorders
blueprint medicines
brian macdonald
cancer
cancer drugs
complement system
deals
deciphera pharmaceuticals
disc medicine
drug development
eli lilly
elizabeta nemeth
endometral cancer
europe blog main
european society for medical oncology
financing
generalized myasthenia gravis
glioblastoma
immune-mediated necrotizing myopathy
incubation
licensing
What
lead
3
×
drug
medicines
new
advance
alternative
anemia
autoimmune
biotech
black
blood
body
cancer
candidate
carry
cells
clinic
companies
deal
diamond
disc
disease
eluded
expensive
having
health
hopes
ipo
iron
launches
leading
lines
little
lungs
medicine
molecular
nears
need
oxygen
pharma
Language
unset
Current search:
lead
×
fda
×
" life sciences "
×
" boston blog main "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma